Loading…

Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution

Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the d...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmaceutical sciences 2012-02, Vol.101 (2), p.641-663
Main Authors: Patel, Jagdishwar R., Carlton, Robert A., Yuniatine, Fnu, Needham, Thomas E., Wu, Lianming, Vogt, Frederick G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303
cites cdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303
container_end_page 663
container_issue 2
container_start_page 641
container_title Journal of pharmaceutical sciences
container_volume 101
creator Patel, Jagdishwar R.
Carlton, Robert A.
Yuniatine, Fnu
Needham, Thomas E.
Wu, Lianming
Vogt, Frederick G.
description Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.
doi_str_mv 10.1002/jps.22800
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_913720256</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915317287</els_id><sourcerecordid>3278525091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</originalsourceid><addsrcrecordid>eNp10VFv0zAQB3ALgVgZPPAFUCSEEA_ZznbsJI9TNwrTBBMd4tFynYvqksaZndCVT49DuiEhePLD_Xz23Z-QlxROKAA73XThhLEC4BGZUcEglUDzx2QWayzlIiuPyLMQNgAgQYin5IgxKIUs5Yzsrj122uveujbRbZUsez-YfvC6SebrWDA9evtzqrs6Ods6363dEJJl5_U-PfcWq-Tchg59iCaM6AZbd2eN3iY726-Ti3atWzOx4Jph7PWcPKl1E_DF4TwmX99f3Mw_pFefFx_nZ1epyWQGaU0lozVnMmOZjr9GpqsSUPAiW7GVrIReGaqxlFywKk4rQSJyoJjlmDMO_Ji8nfp23t0OGHq1tcFg0-gW4xSqpDxnwISM8vVfcuMG38bPKSpozotC0lG9m5TxLgSPteq83Wq_VxTUGIaKYajfYUT76tBxWG2xepD324_gzQHoYHRT-7gmG_44IUDkWR7d6eR2tsH9_19Ul9fL-6fT6YYNPd493ND-u5I5z4X69mkR-7PLRQFf1Oj55DFm8cOiV8FYHEOzHk2vKmf_MeAvaNDA7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517388616</pqid></control><display><type>article</type><title>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</title><source>Wiley-Blackwell Journals</source><source>ScienceDirect Journals</source><creator>Patel, Jagdishwar R. ; Carlton, Robert A. ; Yuniatine, Fnu ; Needham, Thomas E. ; Wu, Lianming ; Vogt, Frederick G.</creator><creatorcontrib>Patel, Jagdishwar R. ; Carlton, Robert A. ; Yuniatine, Fnu ; Needham, Thomas E. ; Wu, Lianming ; Vogt, Frederick G.</creatorcontrib><description>Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.22800</identifier><identifier>PMID: 22095696</identifier><identifier>CODEN: JPMSAE</identifier><language>eng</language><publisher>Hoboken: Elsevier Inc</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry ; Biological and medical sciences ; Chromatography, Liquid ; dissolution ; General pharmacology ; infrared spectroscopy ; Magnetic Resonance Spectroscopy ; mass spectrometry ; Medical sciences ; microscopy ; Microscopy, Electron, Scanning ; Molecular Structure ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Piroxicam - analogs &amp; derivatives ; Piroxicam - chemistry ; Powder Diffraction ; solid dispersion ; solid-state NMR ; solid-state stability ; Solubility ; Spectrophotometry, Infrared ; Spectrophotometry, Ultraviolet ; supersaturation ; thermal analysis ; X-ray diffractometry</subject><ispartof>Journal of pharmaceutical sciences, 2012-02, Vol.101 (2), p.641-663</ispartof><rights>2011 Wiley Periodicals, Inc.</rights><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</citedby><cites>FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.22800$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0022354915317287$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,1417,3549,27924,27925,45574,45575,45780</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25505747$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22095696$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Patel, Jagdishwar R.</creatorcontrib><creatorcontrib>Carlton, Robert A.</creatorcontrib><creatorcontrib>Yuniatine, Fnu</creatorcontrib><creatorcontrib>Needham, Thomas E.</creatorcontrib><creatorcontrib>Wu, Lianming</creatorcontrib><creatorcontrib>Vogt, Frederick G.</creatorcontrib><title>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - chemistry</subject><subject>Biological and medical sciences</subject><subject>Chromatography, Liquid</subject><subject>dissolution</subject><subject>General pharmacology</subject><subject>infrared spectroscopy</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>mass spectrometry</subject><subject>Medical sciences</subject><subject>microscopy</subject><subject>Microscopy, Electron, Scanning</subject><subject>Molecular Structure</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Piroxicam - analogs &amp; derivatives</subject><subject>Piroxicam - chemistry</subject><subject>Powder Diffraction</subject><subject>solid dispersion</subject><subject>solid-state NMR</subject><subject>solid-state stability</subject><subject>Solubility</subject><subject>Spectrophotometry, Infrared</subject><subject>Spectrophotometry, Ultraviolet</subject><subject>supersaturation</subject><subject>thermal analysis</subject><subject>X-ray diffractometry</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp10VFv0zAQB3ALgVgZPPAFUCSEEA_ZznbsJI9TNwrTBBMd4tFynYvqksaZndCVT49DuiEhePLD_Xz23Z-QlxROKAA73XThhLEC4BGZUcEglUDzx2QWayzlIiuPyLMQNgAgQYin5IgxKIUs5Yzsrj122uveujbRbZUsez-YfvC6SebrWDA9evtzqrs6Ods6363dEJJl5_U-PfcWq-Tchg59iCaM6AZbd2eN3iY726-Ti3atWzOx4Jph7PWcPKl1E_DF4TwmX99f3Mw_pFefFx_nZ1epyWQGaU0lozVnMmOZjr9GpqsSUPAiW7GVrIReGaqxlFywKk4rQSJyoJjlmDMO_Ji8nfp23t0OGHq1tcFg0-gW4xSqpDxnwISM8vVfcuMG38bPKSpozotC0lG9m5TxLgSPteq83Wq_VxTUGIaKYajfYUT76tBxWG2xepD324_gzQHoYHRT-7gmG_44IUDkWR7d6eR2tsH9_19Ul9fL-6fT6YYNPd493ND-u5I5z4X69mkR-7PLRQFf1Oj55DFm8cOiV8FYHEOzHk2vKmf_MeAvaNDA7g</recordid><startdate>201202</startdate><enddate>201202</enddate><creator>Patel, Jagdishwar R.</creator><creator>Carlton, Robert A.</creator><creator>Yuniatine, Fnu</creator><creator>Needham, Thomas E.</creator><creator>Wu, Lianming</creator><creator>Vogt, Frederick G.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>American Pharmaceutical Association</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201202</creationdate><title>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</title><author>Patel, Jagdishwar R. ; Carlton, Robert A. ; Yuniatine, Fnu ; Needham, Thomas E. ; Wu, Lianming ; Vogt, Frederick G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - chemistry</topic><topic>Biological and medical sciences</topic><topic>Chromatography, Liquid</topic><topic>dissolution</topic><topic>General pharmacology</topic><topic>infrared spectroscopy</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>mass spectrometry</topic><topic>Medical sciences</topic><topic>microscopy</topic><topic>Microscopy, Electron, Scanning</topic><topic>Molecular Structure</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Piroxicam - analogs &amp; derivatives</topic><topic>Piroxicam - chemistry</topic><topic>Powder Diffraction</topic><topic>solid dispersion</topic><topic>solid-state NMR</topic><topic>solid-state stability</topic><topic>Solubility</topic><topic>Spectrophotometry, Infrared</topic><topic>Spectrophotometry, Ultraviolet</topic><topic>supersaturation</topic><topic>thermal analysis</topic><topic>X-ray diffractometry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Patel, Jagdishwar R.</creatorcontrib><creatorcontrib>Carlton, Robert A.</creatorcontrib><creatorcontrib>Yuniatine, Fnu</creatorcontrib><creatorcontrib>Needham, Thomas E.</creatorcontrib><creatorcontrib>Wu, Lianming</creatorcontrib><creatorcontrib>Vogt, Frederick G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Patel, Jagdishwar R.</au><au>Carlton, Robert A.</au><au>Yuniatine, Fnu</au><au>Needham, Thomas E.</au><au>Wu, Lianming</au><au>Vogt, Frederick G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>2012-02</date><risdate>2012</risdate><volume>101</volume><issue>2</issue><spage>641</spage><epage>663</epage><pages>641-663</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><coden>JPMSAE</coden><abstract>Tenoxicam is a poorly soluble nonsteroidal anti-inflammatory drug. In this work, the solubility of tenoxicam is enhanced using amorphous spray-dried dispersions (SDDs) prepared using two molar equivalents of l-arginine and optionally with 10%–50% (w/w) polyvinylpyrrolidone (PVP). When added to the dispersions, PVP is shown to improve physical properties and also assists in maintaining supersaturation in solution. The dispersions provide a twofold increase over equilibrium solubility at the same pH. The dispersions are characterized using electron microscopy, vibrational spectroscopy, diffuse-reflectance visible spectroscopy, and X-ray powder diffraction. The structures of the dispersions are probed using solid-state nuclear magnetic resonance (SSNMR) experiments applied to the 1H, 13C, and 15N nuclei, including two-dimensional dipolar correlation experiments that detect molecular association and the formation of a glass solution between tenoxicam, l-arginine, and PVP. Other aspects of the amorphous structure, including hydrogen-bonding interactions and the ionization state of tenoxicam and l-arginine, are also explored using SSNMR methods. These methods are used to show that the SDDs contain an amorphous l-arginine salt of tenoxicam in a glass solution that also includes PVP when present. Finally, the dispersions show only a minor decrease in chemical stability during accelerated stability studies relative to a crystalline form of tenoxicam. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.</abstract><cop>Hoboken</cop><pub>Elsevier Inc</pub><pmid>22095696</pmid><doi>10.1002/jps.22800</doi><tpages>23</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 2012-02, Vol.101 (2), p.641-663
issn 0022-3549
1520-6017
language eng
recordid cdi_proquest_miscellaneous_913720256
source Wiley-Blackwell Journals; ScienceDirect Journals
subjects Anti-Inflammatory Agents, Non-Steroidal - chemistry
Biological and medical sciences
Chromatography, Liquid
dissolution
General pharmacology
infrared spectroscopy
Magnetic Resonance Spectroscopy
mass spectrometry
Medical sciences
microscopy
Microscopy, Electron, Scanning
Molecular Structure
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Piroxicam - analogs & derivatives
Piroxicam - chemistry
Powder Diffraction
solid dispersion
solid-state NMR
solid-state stability
Solubility
Spectrophotometry, Infrared
Spectrophotometry, Ultraviolet
supersaturation
thermal analysis
X-ray diffractometry
title Preparation and Structural Characterization of Amorphous Spray-Dried Dispersions of Tenoxicam with Enhanced Dissolution
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T00%3A44%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preparation%20and%20Structural%20Characterization%20of%20Amorphous%20Spray-Dried%20Dispersions%20of%20Tenoxicam%20with%20Enhanced%20Dissolution&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Patel,%20Jagdishwar%20R.&rft.date=2012-02&rft.volume=101&rft.issue=2&rft.spage=641&rft.epage=663&rft.pages=641-663&rft.issn=0022-3549&rft.eissn=1520-6017&rft.coden=JPMSAE&rft_id=info:doi/10.1002/jps.22800&rft_dat=%3Cproquest_cross%3E3278525091%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4640-f1621f326424a220e2ad90e5384b2b6d5abc1ae96352d022606ee301e47e72303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1517388616&rft_id=info:pmid/22095696&rfr_iscdi=true